CAS: 2036081-86-2

JNJ 55511118 is a molecule that binds to glutamate receptors, inhibiting their function. It has been shown to be effective in animal models of pain and neuropathic pain. JNJ 55511118 is administered orally and has a high bioavailability. This drug also has a low risk of interactions with other drugs. Clinical studies are ongoing to determine the appropriate dose for human use.

JNJ-55511118 is a TARP γ8 allosteric modulator with anticonvulsant activity, which can be used in research on chronic operant alcohol self-administration.